000147204 001__ 147204
000147204 005__ 20240229121830.0
000147204 0247_ $$2doi$$a10.1021/acs.est.9b02963
000147204 0247_ $$2pmid$$apmid:31310111
000147204 0247_ $$2ISSN$$a0013-936X
000147204 0247_ $$2ISSN$$a1520-5851
000147204 0247_ $$2altmetric$$aaltmetric:63802427
000147204 037__ $$aDKFZ-2019-02330
000147204 041__ $$aeng
000147204 082__ $$a333.7
000147204 1001_ $$aHu, Chunyun$$b0
000147204 245__ $$aBisphenol A, Chlorinated Derivatives of Bisphenol A and Occurrence of Myocardial Infarction in Patients with Type 2 Diabetes: Nested Case-Control Studies in Two European Cohorts.
000147204 260__ $$aColumbus, Ohio$$bAmerican Chemical Society$$c2019
000147204 3367_ $$2DRIVER$$aarticle
000147204 3367_ $$2DataCite$$aOutput Types/Journal article
000147204 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1580219774_32269
000147204 3367_ $$2BibTeX$$aARTICLE
000147204 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000147204 3367_ $$00$$2EndNote$$aJournal Article
000147204 520__ $$aA positive association between Bisphenol A (BPA) exposure and coronary heart disease has been shown, but not in patients with type 2 diabetes (T2D). During the treatment of drinking water, chlorination leads to the formation of chlorinated derivatives of Bisphenol A (ClxBPA), that have higher estrogenic activity than BPA. No evidence exists for a relationship between exposure to ClxBPA and myocardial infarction in patients with T2D. The objective of this study was to evaluate the relationship between exposure to BPA, ClxBPA and the occurrence of myocardial infarction (MI) in patients with T2D. Two nested case-control studies in two independent European cohorts were performed. Each case with incident MI during follow-up was matched to one control on age, sex, and personal cardiovascular history in the same cohort. Association between baseline urine concentrations of BPA and of ClxBPA and incident MI was determined. Exposure to BPA was 31% in the ESTHER cohort and 18% in the SURDIAGENE cohort. In a meta-analysis of the two studies, occurrence of MI was significantly associated with urine BPA detection: adjusted OR = 1.97 (1.05-3.70), p = 0.04. Exposure to ClxBPA significantly differed in the SURDIAGENE and ESTHER studies: 24% and 8%, respectively (p = 0.0003). It was very strongly associated with MI in the SURDIAGENE cohort with an adjusted odds ratio (OR) of 14.15 (2.77-72.40) but this association was not replicated in the ESTHER study: adjusted OR: 0.17 (0.02-1.23). Whether these results may be explained by different water chlorination processes in France and Germany, resulting in different ClxBPA exposure levels, requires further investigation.
000147204 536__ $$0G:(DE-HGF)POF3-323$$a323 - Metabolic Dysfunction as Risk Factor (POF3-323)$$cPOF3-323$$fPOF III$$x0
000147204 588__ $$aDataset connected to CrossRef, PubMed,
000147204 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, Ben$$b1$$udkfz
000147204 7001_ $$00000-0002-7466-6388$$aVenisse, Nicolas$$b2
000147204 7001_ $$aLimousi, Frédérike$$b3
000147204 7001_ $$aSaulnier, Pierre Jean$$b4
000147204 7001_ $$aAlbouy-Llaty, Marion$$b5
000147204 7001_ $$aDupuis, Antoine$$b6
000147204 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b7$$udkfz
000147204 7001_ $$aMigeot, Virginie$$b8
000147204 7001_ $$aHadjadj, Samy$$b9
000147204 773__ $$0PERI:(DE-600)1465132-4$$a10.1021/acs.est.9b02963$$gVol. 53, no. 16, p. 9876 - 9883$$n16$$p9876 - 9883$$tEnvironmental science & technology$$v53$$x1520-5851$$y2019
000147204 909CO $$ooai:inrepo02.dkfz.de:147204$$pVDB
000147204 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000147204 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000147204 9131_ $$0G:(DE-HGF)POF3-323$$1G:(DE-HGF)POF3-320$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lHerz-Kreislauf-Stoffwechselerkrankungen$$vMetabolic Dysfunction as Risk Factor$$x0
000147204 9141_ $$y2019
000147204 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000147204 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bENVIRON SCI TECHNOL : 2017
000147204 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000147204 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000147204 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000147204 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000147204 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000147204 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000147204 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000147204 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000147204 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000147204 915__ $$0StatID:(DE-HGF)1060$$2StatID$$aDBCoverage$$bCurrent Contents - Agriculture, Biology and Environmental Sciences
000147204 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record
000147204 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000147204 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bENVIRON SCI TECHNOL : 2017
000147204 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000147204 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x1
000147204 980__ $$ajournal
000147204 980__ $$aVDB
000147204 980__ $$aI:(DE-He78)C070-20160331
000147204 980__ $$aI:(DE-He78)C120-20160331
000147204 980__ $$aUNRESTRICTED